BIOSCIENCE REPORTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2022-06-25 ms7000001498510328

偏重的研究方向：bioinformatics
经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应

62 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2021-08-31 146d68e4m35暂无昵称

审稿速度:1.0 | 投稿命中率:95.0
经验分享：审稿极快，对创新性要求不高

73 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2020-09-03 暴躁的萌仔

大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。

141 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2020-07-01 xu4kthor

Editorial Office Check这个状态多久变啊？

160 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2020-12-02 vdujun

这杂志生信分析➕免疫组化的文章吗？

116 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2021-01-01 vdujun

这个杂志已经被纳入中科院预警名单了，还能投吗？

114 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2019-07-11 hongbao

我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表:
请问你的评审过程有这样来回循环的情况吗？

153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？

91 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2023-04-04 ms7000000921596726 来自河北省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：生物化学
经验分享：被警告过了，已经十分严格了。

40 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2020-07-16 GearS

审稿速度:6.0
经验分享：manuscript accepted 后又 in review。这是接收了吗？

143 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1228606, encodeId=4b5212286069c, content=偏重的研究方向：bioinformatics 经验分享：修回去的文章一般多久接受啊，修回去一个月了咋的没有反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6058159615, createdName=ms7000001498510328, createdTime=Sat Jun 25 16:31:17 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013251, encodeId=a2e01013251d6, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：审稿极快，对创新性要求不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=95665170524, createdName=146d68e4m35暂无昵称, createdTime=Tue Aug 31 18:20:23 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882577, encodeId=a31f8825e71c, content=大家好，最近投了片综述，编辑回信需要institutional email address of one of the authors，这个是什么意思，没有怎么办，求大神相助，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79dc2118916, createdName=暴躁的萌仔, createdTime=Thu Sep 03 22:25:27 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800834, encodeId=c8d8800834d7, content=Editorial Office Check这个状态多久变啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Wed Jul 01 23:00:39 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904281, encodeId=7c78904281d8, content=这杂志生信分析➕免疫组化的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Wed Dec 02 12:39:39 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912808, encodeId=9cd291280834, content=这个杂志已经被纳入中科院预警名单了，还能投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Fri Jan 01 02:10:35 CST 2021, time=2021-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573550, encodeId=0d565e35508f, content=我的就是来回循环的，under associate editor review,然后peer review,然后又under AE REVIEW,又peer review153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, beContent=153****7553暂无昵称 2019-05-27 00:00:00 发表: 请问你的评审过程有这样来回循环的情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=080d2320110, createdName=hongbao, createdTime=Thu Jul 11 00:00:00 CST 2019, time=2019-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2123632, encodeId=ef412123632fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：生物化学 经验分享：被警告过了，已经十分严格了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dd56153548, createdName=ms7000000921596726, createdTime=Tue Apr 04 10:26:27 CST 2023, time=2023-04-04, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=802989, encodeId=8a698029891f, content=审稿速度:6.0 经验分享：manuscript accepted 后又 in review。这是接收了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AIyXibemdRBLfdgufySRMdnUUjZic11r7VQE6u3nqyFYq0oes0vULMbcZAhmaxniciaibUfTfYINlJSYKAkPJ7EAI9A/132, createdBy=c8241981689, createdName=GearS, createdTime=Thu Jul 16 14:37:13 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882490, encodeId=2c6a88249080, content=under peer review一般要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJxic7uHlNxcSIPRsktjtqA25f0bnicvrDoFbh3bH8hTCbWY0DS0Kviblck0yAib4H4GJXp0vT3iawlGJQ/132, createdBy=d2882217101, createdName=xu4kthor, createdTime=Thu Sep 03 15:11:28 CST 2020, time=2020-09-03, status=1, ipAttribution=)]

2020-09-03 xu4kthor

under peer review一般要多久啊

139 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务